Nathan Ackerman, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-1243 |
Dr. Jonathan Lee Mcjunkin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3105 Fields South Dr, Champaign, IL 61822 Phone: 217-902-3277 Fax: 217-383-4451 |
Ashok A Jagasia, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3101 Fields South Dr, Champaign, IL 61822 Phone: 217-366-1243 |
Dr. William D. Youngerman, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 101 W University Ave, Champaign, IL 61820 Phone: 217-366-1243 |
Dr. Peter S Dumich, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2609 S Nottingham Ct, Champaign, IL 61821 Phone: 217-352-1668 Fax: 217-352-6882 |
News Archive
A team of researchers at the University of California in Irvine, California has demonstrated a novel process to produce cell-sized lipid vesicles (CLVs) from microfluidically generated double emulsion templates by investigating the interfacial parameters that control double emulsion stability for storage, and their subsequent dewetting to form multisomes or GUVs (subsets of CLVs).
Pfizer Inc. has agreed to provide the University of Rochester Medical Center (URMC) with a unique set of electrocardiographic data that will help researchers develop new methods to ensure the safety of experimental drugs.
The Ensign Group, Inc., the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has placed mortgages on six of the Company's 27 unencumbered properties to secure a $40 million five-year term loan from GE Capital's Healthcare Financial Services business.
The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.
A randomized, controlled, multi-center trial has found that cardiac resynchronization therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in patients with Class III heart failure, including mechanical problems that disrupt the heart's normal rhythm and a moderately prolonged QRS complex as demonstrated on EKG.
› Verified 6 days ago